Manufacturing & Analytical Characterization
Sreejit Menon, PhD
Head of Life Sciences R&D, North America
Croda Inc.
Plainsboro, New Jersey
Garima Sinha, PhD
Lead Applications Scientist
Croda Pharma
Plainsboro, New Jersey
Description: The biomanufacturing process consists of several critical stages that impact the final yield and safety profile of biological products. Two pivotal factors in this process involve maintaining cell health during the upstream phase and viral inactivation during the downstream phase. Using high-purity, low molecular-weight poloxamer 188 in cell culture media enhances cell health. Subsequently, during downstream processing to meet the FDA's viral inactivation requirement, a non-ionic, sustainable detergent can significantly reduce the viral burden.